Advertisement

Journal of Neuro-Oncology

, Volume 20, Issue 1, pp 17–25 | Cite as

Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-α in the rat

  • James L. Wright
  • Randall E. Merchant
Laboratory Investigation

Summary

Human recombinant tumor necrosis factor-α (rTNF-α) was administered to normal Fischer 344 rats by stereotaxic intracerebral (IC) injection. Animals receiving a single injection of either 6 x 104 U rTNF-α or an equivalent volume of excipient (vehicle) in their right parietal lobe. In order to demonstrate any effects rTNF-α might have on the blood-brain barrier (BBB), two studies were conducted, one employing exogenous horseradish peroxidase (HRP, 44 kD) as a tracer of BBB permeability and the other using endogenous IgG (150 kD). Rats given rTNF-α showed transitory BBB permeability to HRP by 24 hours post-injection; this BBB compromise was determined to be no longer than 60 hours. In the other study, IgG was seen to cross the BBB by 48 hours post-rTNF-α injection. Alternatively, rats injected IC with excipient showed only limited BBB opening as a result of injection-induced trauma. We conclude that human rTNF-α, injected IC into normal rats triggers a temporary breakdown in BBB integrity which begins sometimes between 12 and 24 hours post-injection, is large enough to permit macromolecules of at least 150 kD to pass, and resolves by 72 hours post-injection.

Key words

TNF-α blood-brain barrier toxicity histopathology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gordon CR, Merchant RE, Marmarou A, Rice CD, Marsh JT, Young HF: Effect of murine recombinant interleukin-l on brain edema in the rat. Acta Neurochir Suppl 51: 268–270, 1990Google Scholar
  2. 2.
    Kido G, Wright JL, Merchant RE: Acute effects of human recombinant tumor necrosis factor-a on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model. J Neuro-Oncol 10: 95–109, 1991Google Scholar
  3. 3.
    Rice CD, Merchant RE: Systemic treatment with murine recombinant interleukin-lβ inhibits the growth and progression of malignant glioma in the rat. J Neuro-Oncol 13: 43–55, 1992Google Scholar
  4. 4.
    Watts RG, Wright JL, Atkinson LL, Merchant RE: Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2. Neurosurgery 25: 202–208, 1989PubMedGoogle Scholar
  5. 5.
    Watts RG, Merchant RE: Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma. Neurosurgery 31: 89–99, 1992PubMedGoogle Scholar
  6. 6.
    Wright JL, Merchant RE: Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-a in the rat. Acta Neuropathol 85: 93–100, 1992PubMedGoogle Scholar
  7. 7.
    Ellison MD, Povlishock JT, Merchant RE: Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion. Cancer Res 47: 5765–5770, 1987PubMedGoogle Scholar
  8. 8.
    Ellison MD, Krieg RJ, Merchant RE: Cerebral vasomotor responses after recombinant interleukin-2 infusion. Cancer Res 50: 4377–4381, 1990PubMedGoogle Scholar
  9. 9.
    Merchant RE, Grant AJ, Merchant LH, Young HF: Adoptive immunotherapy for recurrent glioblastoma multiforme using lymphokine activated killer (LAK) cells and recombinant interleukin-2. Cancer 62: 665–671, 1988PubMedGoogle Scholar
  10. 10.
    Merchant RE, Merchant LH, Cook SH, McVicar DW, Young HF: Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (IL-2) for the treatment of patients with malignant brain tumor. Neurosurgery 23: 725–732, 1988PubMedGoogle Scholar
  11. 11.
    Clark I, Ilschner S, MacMicking J, Cowden W: TNF andPlasmodium berghei ANKA-induced cerebral malaria. Immuno Lett 25: 195–198, 1990Google Scholar
  12. 12.
    Braquet P, Hosford D, Braquet M, Bourgain R, Bussolino F: Role of cytokines and platelet-activating factor in microvascular immune injury. Int Arch Allergy Appl Immunol 88: 88–100, 1989PubMedGoogle Scholar
  13. 13.
    Movat HZ: Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury. J Lab Clin Med 110: 668–681, 1987PubMedGoogle Scholar
  14. 14.
    Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, Tuomanen E: The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 171: 439–448, 1990PubMedGoogle Scholar
  15. 15.
    Quagliarello V, Wispelwey B, Long W, Scheid W: Recombinant interleukin-l induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 87: 1360–1366, 1991PubMedGoogle Scholar
  16. 16.
    Sharief M, Ciardi M, Thompson E: Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-l beta. J Infect Dis 166: 350–358, 1992PubMedGoogle Scholar
  17. 17.
    Mullin JM, Snock KV: Effects of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 50: 2172–2176, 1990PubMedGoogle Scholar
  18. 18.
    Saegusa Y, Ziff M, Weikovich L, Cavender D: Effect of inflammatory cytokines on human endothelial cell proliferation. J Cell Physiol 142: 488–495, 1990PubMedGoogle Scholar
  19. 19.
    Yoshida S, Minakawa T, Takai N, Tanaka R: Effects of cytokines on cultured microvascular endothelial cells derived from gerbil brain. Neurosurgery 25: 373–377, 1989PubMedGoogle Scholar
  20. 20.
    Andersson P-B, Perry V, Gordon S: Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med 176: 255–259, 1992PubMedGoogle Scholar
  21. 21.
    Kuroiwa T, Cahn R, Juhler M, Goping G, Campbell G, Klatzo I: Role of extracellular proteins in the dynamics of vasogenic brain edema. Acta Neuropathol 66: 3–11, 1985PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1994

Authors and Affiliations

  • James L. Wright
    • 1
  • Randall E. Merchant
    • 1
    • 2
  1. 1.Department of 1 AnatomyViginia Commonwealth University, Medical College of VirginiaRichmondUSA
  2. 2.Department of Surgery, Division of NeurosurgeryViginia Commonwealth University, Medical College of VirginiaRichmondUSA

Personalised recommendations